Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

154833 Press Releases
DateTitleCompany
21 Feb 17 Minerva Neurosciences to Host R&D Day Focused on Unmet Needs and Emerging Treatment Strategies in Schizophrenia Minerva Neurosciences, Inc.,
Published by
GlobeNewswire
21 Feb 17 RedHill Biopharma Completes Treatment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis RedHill Biopharma Ltd.,
Published by
GlobeNewswire
21 Feb 17 XBiotech Reports Affirmative Interim Analysis of Global Phase 3 Colorectal Cancer Study XBiotech, Inc,
Published by
GlobeNewswire
21 Feb 17 Abeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR Congress Abeona Therapeutics Inc,
Published by
GlobeNewswire
21 Feb 17 Modern Acupuncture™ Partners With World Renowned Acupuncturist and Educator Robert Doane Modern Acupuncture,
Published by
PR Newswire
21 Feb 17 Using Mono-Allelic Mass Spectrometry Data to Improve Epitope Prediction Algorithms Published in Immunity Neon Therapeutics, Inc.,
Published by
Business Wire
21 Feb 17 Cerus to Release Fourth Quarter and Year End 2016 Results on March 7, 2017 Cerus Corporation,
Published by
Business Wire
21 Feb 17 EpiCast Report: Myelofibrosis - Epidemiology Forecast to 2025 - Research and Markets Research and Markets,
Published by
Business Wire
21 Feb 17 Selexis SA Inks Agreement for Applications in Cancer and Infectious Disease Selexis SA,
Published by
Business Wire
21 Feb 17 PrescribeWellness Shows Continued Growth with Two Key Appointments PrescribeWellness,
Published by
Business Wire
21 Feb 17 Protalex Provides Update on US and EU Studies of PRTX-100 to Treat Immune Thrombocytopenia Protalex, Inc.,
Published by
Business Wire
21 Feb 17 Syros’ Drug Discovery Research in Immuno-Oncology Highlighted at UCSD Moores Cancer Center Symposium Syros Pharmaceuticals, Inc.,
Published by
Business Wire
21 Feb 17 Nativis Rounds Out Board of Directors with Appointment of Dr. Una Ryan Nativis Inc.,
Published by
Business Wire
21 Feb 17 FORMA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research FORMA Therapeutics,
Published by
Business Wire
21 Feb 17 H3 Biomedicine Announces Appointment of Peter G. Smith, Ph. D., to Chief Scientific Officer H3 Biomedicine,
Published by
Business Wire
21 Feb 17 Two Pore Guys to Present at Point-of-Care Diagnostics Symposium at the Molecular Medicine Tri-Conference Two Pore Guys, Inc.,
Published by
Business Wire
21 Feb 17 Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin by the U.S. Food and Drug Administration Pfizer Inc.,
Published by
Business Wire
21 Feb 17 Catherine D. Strader, Ph.D., Joins Acorda Therapeutics Board of Directors Acorda Therapeutics, Inc.,
Published by
Business Wire
21 Feb 17 N-of-One® Dramatically Speeds High-Accuracy Interpretation of the Illumina TrueSight Tumor170 Cancer Panel N-of-One, Inc.,
Published by
Business Wire
21 Feb 17 PetLife Pharmaceutical Taps National Public Relations Firm to Help Bring to Market Cancer Treatment Originally Developed by Cuba PetLife Pharmaceuticals, Inc.,
Published by
Business Wire
21 Feb 17 CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates CohBar, Inc.,
Published by
Business Wire
21 Feb 17 Second Sight Announces Professor Stanislao Rizzo Has Completed His 30th Implant of the Argus II Retinal Prosthesis Second Sight Medical Products, Inc.,
Published by
Business Wire
21 Feb 17 CEL-SCI Scientist Presents New Findings for Rheumatoid Arthritis Treatment Vaccine at Conference CEL-SCI Corporation,
Published by
Business Wire
21 Feb 17 Anders Hove, MD Joins ARCA biopharma Board of Directors ARCA biopharma, Inc.,
Published by
Business Wire
21 Feb 17 Sarepta Therapeutics Agrees to Sale of Priority Review Voucher for $125M Sarepta Therapeutics, Inc.,
Published by
Business Wire
21 Feb 17 The Medicines Company Announces FDA Filing Acceptance of New Drug Application for Intravenous Antibiotic Carbavance® (meropenem-vaborbactam) The Medicines Company,
Published by
Business Wire
21 Feb 17 Market Research and Forecast of Antineoplastic Drugs in China 2016-2021 - Market will Reach More than RMB250 Billion - Research and Markets Research and Markets,
Published by
Business Wire
21 Feb 17 Cellect Announces Positive Clinical Trial Results Published by
GlobeNewswire
21 Feb 17 Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate Published by
GlobeNewswire
21 Feb 17 Stemline Therapeutics Provides Update on Clinical Programs Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.